GDF9 anticorps (AA 320-454)
-
- Antigène Voir toutes GDF9 Anticorps
- GDF9 (Growth Differentiation Factor 9 (GDF9))
-
Épitope
- AA 320-454
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp GDF9 est non-conjugé
-
Application
- ELISA, Immunohistochemistry (IHC)
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human Growth/differentiation factor 9 protein (320-454AA)
- Isotype
- IgG
- Top Product
- Discover our top product GDF9 Anticorps primaire
-
-
- Indications d'application
- Recommended dilution: IHC:1:200-1:500,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- GDF9 (Growth Differentiation Factor 9 (GDF9))
- Autre désignation
- GDF9 (GDF9 Produits)
- Synonymes
- anticorps GDF-9, anticorps zgc:123030, anticorps Gdf-9, anticorps growth differentiation factor 9, anticorps GDF9, anticorps gdf9, anticorps Gdf9
- Sujet
-
Background: Required for ovarian folliculogenesis. Promotes primordial follicle development. Stimulates granulosa cell proliferation. Promotes cell transition from G0/G1 to S and G2/M phases, through an increase of CCND1 and CCNE1 expression, and RB1 phosphorylation. It regulates STAR expression and cAMP-dependent progesterone release in granulosa and thecal cells. Attenuates the suppressive effects of activin A on STAR expression and progesterone production by increasing the expression of inhibin B. It suppresses FST and FSTL3 production in granulosa-lutein cells.
Aliases: GDF9Growth/differentiation factor 9 antibody, GDF-9 antibody
- UniProt
- O60383
-